NeoGenomics, Inc. (NEO) vs OPKO Health, Inc. (OPK)
- NeoGenomics, Inc. NEO 16.65 −3.48%
- OPKO Health, Inc. OPK 1.53 −4.97%
NeoGenomics, Inc. and OPKO Health, Inc. are both Diagnostics & Research companies. NeoGenomics, Inc. is the larger, with a market value of $2.2B against $1.2B — 1.8× the size. NeoGenomics, Inc. grew revenue faster over the last twelve months: 11.2% against −11.5%. NeoGenomics, Inc. has the higher net margin (−6.77% vs −12.4%) and the lower return on invested capital (−4.20% vs −2.45%). Across the 18 metrics below, NeoGenomics, Inc. leads on 11 and OPKO Health, Inc. on 7.
Valuation
Profitability
| Metric | NEO | OPK | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 43.92% | 40.77% | 50.89% |
| Operating margin | (8.93%) | (8.21%) | (8.57%) |
| Net margin | (6.77%) | (12.40%) | (6.37%) |
| Free cash flow margin | (0.69%) | (22.75%) | 0.00% |
| Return on equity | (6.33%) | (5.88%) | (2.92%) |
| Return on assets | (3.78%) | (3.83%) | (6.71%) |
| Return on invested capital | (4.20%) | (2.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack